Functions of the N-glycans of rat leukemia inhibitory factor expressed in chinese hamster ovary cells

Ken Sasai, Jun Ichi Aikawa, Sakura Saburi, Hideaki Tojo, Satoshi Tanaka, Tomoya Ogawa, Kunio Shiota

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Leukemia inhibitory factor (LIF) is a pluripotent growth factor which acts in various cell systems. LIF is a glycoprotein containing six putative N-glycosylation sites. We established Chinese hamster ovary (CHO) cell lines to evaluate the biological roles of the N-glycosylation in rat LIF (rLIF). The bioactivity of rLIF was evaluated in two different bioassay systems using F9 and DA-1a cells. Employing site directed mutagenesis, six N-glycosylation-deficient LIF mutants were generated by replacing each asparagine residue (N) (at positions N9, N34, N63, N73, N96, and N116) by glutamine (Q). The resultant mutants showed similar activity in the bioassay using F9 cells. However, N34Q was about 3 times more potent than the wild-type rLIF in the assay using DA-1a cells. These findings suggest that the presence of N-glycan at N34 suppresses cell proliferation. In contrast, N63Q was about 2.5 times less potent than the wild-type rLIF indicating the pivotal role of N63 glycosylation for rLIF bioactivity. Taken together, our data suggest that the N-glycans of LIF play different roles depending on the cell line and that glycosylation of each specific residue contributes differently to its bioactivity.

Original languageEnglish
Pages (from-to)999-1003
Number of pages5
JournalJournal of Biochemistry
Volume124
Issue number5
Publication statusPublished - 1998 Nov
Externally publishedYes

Fingerprint

Glycosylation
Leukemia Inhibitory Factor
Cricetulus
Polysaccharides
Rats
Ovary
Cells
Bioactivity
Bioassay
Biological Assay
Cell Line
Mutagenesis
Asparagine
Cell proliferation
Site-Directed Mutagenesis
Glutamine
Assays
Intercellular Signaling Peptides and Proteins
Glycoproteins
Cell Proliferation

Keywords

  • DA-1a
  • F9
  • Leukemia inhibitory factor
  • N-glycosylation
  • Recombinant protein

ASJC Scopus subject areas

  • Biochemistry

Cite this

Sasai, K., Aikawa, J. I., Saburi, S., Tojo, H., Tanaka, S., Ogawa, T., & Shiota, K. (1998). Functions of the N-glycans of rat leukemia inhibitory factor expressed in chinese hamster ovary cells. Journal of Biochemistry, 124(5), 999-1003.

Functions of the N-glycans of rat leukemia inhibitory factor expressed in chinese hamster ovary cells. / Sasai, Ken; Aikawa, Jun Ichi; Saburi, Sakura; Tojo, Hideaki; Tanaka, Satoshi; Ogawa, Tomoya; Shiota, Kunio.

In: Journal of Biochemistry, Vol. 124, No. 5, 11.1998, p. 999-1003.

Research output: Contribution to journalArticle

Sasai, K, Aikawa, JI, Saburi, S, Tojo, H, Tanaka, S, Ogawa, T & Shiota, K 1998, 'Functions of the N-glycans of rat leukemia inhibitory factor expressed in chinese hamster ovary cells', Journal of Biochemistry, vol. 124, no. 5, pp. 999-1003.
Sasai K, Aikawa JI, Saburi S, Tojo H, Tanaka S, Ogawa T et al. Functions of the N-glycans of rat leukemia inhibitory factor expressed in chinese hamster ovary cells. Journal of Biochemistry. 1998 Nov;124(5):999-1003.
Sasai, Ken ; Aikawa, Jun Ichi ; Saburi, Sakura ; Tojo, Hideaki ; Tanaka, Satoshi ; Ogawa, Tomoya ; Shiota, Kunio. / Functions of the N-glycans of rat leukemia inhibitory factor expressed in chinese hamster ovary cells. In: Journal of Biochemistry. 1998 ; Vol. 124, No. 5. pp. 999-1003.
@article{87a4ec0a51d0421085a1efd7acde805d,
title = "Functions of the N-glycans of rat leukemia inhibitory factor expressed in chinese hamster ovary cells",
abstract = "Leukemia inhibitory factor (LIF) is a pluripotent growth factor which acts in various cell systems. LIF is a glycoprotein containing six putative N-glycosylation sites. We established Chinese hamster ovary (CHO) cell lines to evaluate the biological roles of the N-glycosylation in rat LIF (rLIF). The bioactivity of rLIF was evaluated in two different bioassay systems using F9 and DA-1a cells. Employing site directed mutagenesis, six N-glycosylation-deficient LIF mutants were generated by replacing each asparagine residue (N) (at positions N9, N34, N63, N73, N96, and N116) by glutamine (Q). The resultant mutants showed similar activity in the bioassay using F9 cells. However, N34Q was about 3 times more potent than the wild-type rLIF in the assay using DA-1a cells. These findings suggest that the presence of N-glycan at N34 suppresses cell proliferation. In contrast, N63Q was about 2.5 times less potent than the wild-type rLIF indicating the pivotal role of N63 glycosylation for rLIF bioactivity. Taken together, our data suggest that the N-glycans of LIF play different roles depending on the cell line and that glycosylation of each specific residue contributes differently to its bioactivity.",
keywords = "DA-1a, F9, Leukemia inhibitory factor, N-glycosylation, Recombinant protein",
author = "Ken Sasai and Aikawa, {Jun Ichi} and Sakura Saburi and Hideaki Tojo and Satoshi Tanaka and Tomoya Ogawa and Kunio Shiota",
year = "1998",
month = "11",
language = "English",
volume = "124",
pages = "999--1003",
journal = "Journal of Biochemistry",
issn = "0021-924X",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Functions of the N-glycans of rat leukemia inhibitory factor expressed in chinese hamster ovary cells

AU - Sasai, Ken

AU - Aikawa, Jun Ichi

AU - Saburi, Sakura

AU - Tojo, Hideaki

AU - Tanaka, Satoshi

AU - Ogawa, Tomoya

AU - Shiota, Kunio

PY - 1998/11

Y1 - 1998/11

N2 - Leukemia inhibitory factor (LIF) is a pluripotent growth factor which acts in various cell systems. LIF is a glycoprotein containing six putative N-glycosylation sites. We established Chinese hamster ovary (CHO) cell lines to evaluate the biological roles of the N-glycosylation in rat LIF (rLIF). The bioactivity of rLIF was evaluated in two different bioassay systems using F9 and DA-1a cells. Employing site directed mutagenesis, six N-glycosylation-deficient LIF mutants were generated by replacing each asparagine residue (N) (at positions N9, N34, N63, N73, N96, and N116) by glutamine (Q). The resultant mutants showed similar activity in the bioassay using F9 cells. However, N34Q was about 3 times more potent than the wild-type rLIF in the assay using DA-1a cells. These findings suggest that the presence of N-glycan at N34 suppresses cell proliferation. In contrast, N63Q was about 2.5 times less potent than the wild-type rLIF indicating the pivotal role of N63 glycosylation for rLIF bioactivity. Taken together, our data suggest that the N-glycans of LIF play different roles depending on the cell line and that glycosylation of each specific residue contributes differently to its bioactivity.

AB - Leukemia inhibitory factor (LIF) is a pluripotent growth factor which acts in various cell systems. LIF is a glycoprotein containing six putative N-glycosylation sites. We established Chinese hamster ovary (CHO) cell lines to evaluate the biological roles of the N-glycosylation in rat LIF (rLIF). The bioactivity of rLIF was evaluated in two different bioassay systems using F9 and DA-1a cells. Employing site directed mutagenesis, six N-glycosylation-deficient LIF mutants were generated by replacing each asparagine residue (N) (at positions N9, N34, N63, N73, N96, and N116) by glutamine (Q). The resultant mutants showed similar activity in the bioassay using F9 cells. However, N34Q was about 3 times more potent than the wild-type rLIF in the assay using DA-1a cells. These findings suggest that the presence of N-glycan at N34 suppresses cell proliferation. In contrast, N63Q was about 2.5 times less potent than the wild-type rLIF indicating the pivotal role of N63 glycosylation for rLIF bioactivity. Taken together, our data suggest that the N-glycans of LIF play different roles depending on the cell line and that glycosylation of each specific residue contributes differently to its bioactivity.

KW - DA-1a

KW - F9

KW - Leukemia inhibitory factor

KW - N-glycosylation

KW - Recombinant protein

UR - http://www.scopus.com/inward/record.url?scp=0031787370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031787370&partnerID=8YFLogxK

M3 - Article

VL - 124

SP - 999

EP - 1003

JO - Journal of Biochemistry

JF - Journal of Biochemistry

SN - 0021-924X

IS - 5

ER -